A Phase IV Enhanced Safety Surveillance Study of ACAM2000 in Military Personnel.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 May 2017
At a glance
- Drugs ACAM 2000 (Primary)
- Indications Smallpox
- Focus Adverse reactions
- Sponsors Sanofi; sanofi pasteur
- 16 May 2017 Planned End Date changed from 1 Sep 2016 to 1 Dec 2017.
- 16 May 2017 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2017.
- 16 May 2017 Status changed from recruiting to active, no longer recruiting.